Aileen Wang
Financieel Directeur/CFO bij CLOVER BIOPHARMACEUTICALS, LTD.
Actieve functies van Aileen Wang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Financieel Directeur/CFO | 01-07-2022 | - |
| Corporate Officer/Principal | 01-03-2021 | - |
Loopbaan van Aileen Wang
Eerdere bekende functies van Aileen Wang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | - | - |
Opleiding van Aileen Wang
| The Pennsylvania State University | Masters Business Admin |
| Shanghai Jiao Tong University | Undergraduate Degree |
Statistieken
Internationaal
| China | 3 |
| Verenigde Staten | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Beurs
- Insiders
- Aileen Wang
- Ervaring
